CytoSorbents Appoints Peter J. Mariani As Chief Financial Officer, Effective August 14, 2024; Kathleen P. Bloch Retires As CFO, Will Continue As Consultant To Ensure Smooth Transition
Portfolio Pulse from Benzinga Newsdesk
CytoSorbents has appointed Peter J. Mariani as the new Chief Financial Officer, effective August 14, 2024. Kathleen P. Bloch, the retiring CFO, will continue as a consultant to ensure a smooth transition.
August 13, 2024 | 8:41 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
CytoSorbents appoints Peter J. Mariani as the new CFO, effective August 14, 2024. Kathleen P. Bloch, the retiring CFO, will continue as a consultant to ensure a smooth transition.
The appointment of a new CFO and the continued involvement of the retiring CFO as a consultant should ensure a smooth transition, which is generally positive for investor confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100